市場調査レポート
商品コード
1439694
医療機器受託製造 - 世界市場の考察、競合情勢、市場予測(2030年)Medical Device Contract Manufacturing - Market Insights, Competitive Landscape, and Market Forecast - 2030 |
● お客様のご希望に応じて、既存データの加工や未掲載情報(例:国別セグメント)の追加などの対応が可能です。 詳細はお問い合わせください。
医療機器受託製造 - 世界市場の考察、競合情勢、市場予測(2030年) |
出版日: 受注後更新
発行: DelveInsight
ページ情報: 英文 150 Pages
納期: 2~10営業日
|
世界の医療機器受託製造の市場規模は、予測期間(2024年~2030年)にCAGRで10.82%の成長が見込まれます。市場は、複雑かつ安価な医療機器への需要の増加などの多くの理由により、製品需要が爆発的に増加しています。また、慢性疾患の有病率の上昇や、今後数年間における老年人口の増加も一因となっています。さらに、発展途上国市場における病院数の増加や体外診断用医薬品検査数の増加も、2024年~2030年の予測期間に市場の成長動向を確立する上で重要な役割を果たす見込みです。
医療機器受託製造の市場力学
医療機器受託製造市場の主な成長促進要因の1つは、世界中での慢性疾患の有病率の上昇であり、これが医療機器受託製造の需要に影響を与えると予測されます。例えば、世界保健機関(WHO)(2023)が提供したデータによると、非伝染性疾患により毎年約4,100万人が死亡しており、世界全体の死亡者数の71%を占めています。
さらに、世界中の心血管疾患の増加も医療機器の需要の増加につながり、医療機器受託製造市場の成長を増大させます。例えば、世界保健機関(WHO)(2022)によると、心血管疾患は毎年約1,790万人の死亡を引き起こす世界の死亡の主因です。増加する心血管疾患に関連する死亡の流行もまた、医療機器は元来死亡率の抑制を引き起こすために必要であることから、医療機器の需要を増加させ、医療機器受託製造市場全体の成長を増大させます。
医療機器受託製造の需要の増加のもう1つの大きな要因が、医療と生物医療における技術の進歩であり、これが予測期間に医療機器受託製造の需要を促進すると見込まれます。例えば、ある医療企業は現在、安全で痛みのない全身MRIスキャンを提供しており、これは脳腫瘍、脊椎の悪化、肺病変、心臓病など、症状が出る前に複数の異常を検出することができます。さらに、新しいがん血液検査は、患者の血液サンプルから体内の50種類以上のがんを一度に分析できるため、さまざまな種類の疾患を見逃すことなく発見することができます。がん血液検査へのニーズと需要の高まりにより、医療機器受託製造サービスの需要が増加し、医療機器受託製造市場全体の成長につながります。
しかし、病院の予算の制約や、そのような複雑な医療機器の操作に求められる熟練した専門家の不足が、2022年~2027年の予測期間に医療機器受託製造市場の成長抑制要因となる可能性があります。
上記の要因に加え、医療機器受託製造市場はCOVID-19パンデミックの強制によってわずかにプラスの影響を受けました。OEMとCMOの統合が急増しており、COVID-19患者をサポートするために必要とされた救命人工呼吸器に対する患者の差し迫った要求を満たすために企業が現在奮闘していることから、シフトは非常に重要です。
多様な業界で活動していた企業は、あらゆる面でメドテックを優先するようになっています。さまざまな医療機器メーカーが緊急に医療部品の需要を受け、検査キットから人工呼吸器の部品に至るまで、医療機器の緊急生産を必要としていました。
医療機器受託製造市場のセグメント分析
医療機器受託製造市場の製品タイプセグメントでは、体外診断(IVD)機器が2023年に大きな収益シェアを占めると推定されます。これは、世界の体外診断検査数の増加、医療インフラの発展と発展途上地域における病院数の増加、COVID-19診断に向けた体外診断キットの使用の増加などのさまざまな要因によるものと考えられます。
体外診断医療機器にはさまざまな利点があり、妊娠中の自己検査や糖尿病患者の血糖値検査から臨床検査室で行われる先進の診断まで、さまざまな用途で使用されています。IVD機器はエンドユーザーの採用率が非常に高いため、医療施設での使用は継続的に加速しています。ポイントオブケア(POC)機器に対する需要や、疾患のモニタリング、診断、予防の能力も、このセグメントの成長に寄与しています。さらに、SARS-CoV-2ウイルスの感染診断に使用されることも、IVD市場の成長を増大させています。IVD検査はCOVID-19の検出において、ウイルスの迅速な検出や、治療やウイルスの検出に役立つ非侵襲性のポイントオブケア機器であるといった利点を提供します。
当レポートでは、世界の医療機器受託製造市場について調査分析し、市場規模と予測、促進要因と課題、企業と製品のプロファイルなどを提供しています。
Medical Device Contract Manufacturing Market By Device Type (Ivd Devices, Drug Delivery Devices, Diagnostic Imaging Devices, Patient Monitoring Devices, Cardiovascular Devices, Orthopedic Devices And Others), By Service (Device Development And Manufacturing Services, Quality Management Services, And Final Goods Assembly Services), By Application (Laparoscopy, Pulmonary, Urology & Gynecology, Cardiovascular, Orthopedic, And Others), and by geography is expected to grow at an appreciable CAGR forecast till 2030 owing to rising advancements in healthcare, medical as well as biomedical technology, rising expansion and development of skilled and technologically superior healthcare infrastructure as well as medical facilities
The global medical device contract manufacturing market is projected to grow at a 10.82% CAGR during the forecast period (2024-2030). The medical device contract manufacturing market is witnessing an explosion in product demand owing to numerous reasons such as the increasing demand of the complex and affordable medical devices. Another contributing factor is the rising prevalence of chronic disorders and the increasing geriatric population in coming years. Additionally, the rising numbers of hospitals in the developing countries and the rising IVD test volume will also play a key role in establishing an upward growth trend in the medical device contract manufacturing market during the forecast period from 2024 to 2030.
Medical Device Contract Manufacturing Market Dynamics:
One of primary factor driving the Medical Device Contract Manufacturing market growth is the rising prevalence of chronic diseases across the globe, which is expected to influence the demand for Medical Device Contract Manufacturing. For instance, as per the data provided by the World Health Organization (2023), non-communicable diseases had killed approximately 41 million people every year, accounting a total of 71% of all the deaths globally.
Additionally, the rise in cardiovascular diseases across the globe will also lead to an increase in the demand of medical devices, thereby augmenting the growth of the medical device contract manufacturing market. For instance, as per the World Health Organization 2022, cardiovascular diseases are the leading cause of death globally responsible for causing about 17.9 million deaths every year. The rising prevalence of death associated with the increasing cardiovascular diseases will also increase the demand of the medical devices as they are essentially required to cause a restraint in the death rate, thereby increasing the overall medical device contract manufacturing market growth.
Another prominent factor responsible for the increasing demand of Medical Device Contract Manufacturing is the rising advancements in the healthcare, medical and biomedical technologies which is expected to drive the demand for Medical Device Contract Manufacturing during the forecast period. For instance, certain healthcare companies are now offering full body MRI-scans that are safe and painless and are capable of detecting multiple abnormalities before the onset of symptoms, comprising brain tumors, spinal deterioration, pulmonary lesions, heart disease and more. Additionally, new cancer blood tests are also capable of analyzing a patient's blood sample for more than fifty different types of cancer in the body at once, thereby allowing the detection of different types of diseases without letting them go undetected. Owing to an increase in the rising need and demand for cancer blood tests, there will be an increase in the demand of medical devices contract manufacturing services, leading to an overall growth of the medical device contract manufacturing market growth.
However, the budgetary constraints of hospitals and the lack of skilled professionals required for operating such complex medical devices can cause a restraint in the medical device contract manufacturing market growth during the forecast period of 2022-27.
Besides the above-mentioned factors, the Medical Device Contract Manufacturing market was impacted slightly positive by the imposition of COVID-19 pandemic. There has been a surge in the consolidation between the Original equipment Manufacturers and Medical Device Contract Manufacturing Organizations (CMOs), a shift that is extremely important as the companies are now struggling to fulfill the emergent demands of patients for life-saving ventilators that were required to support the coronavirus victims.
Companies that were operating in versatile industries have prioritized Medtech in all aspects. Various medical device manufacturers had received demand of medical components on an urgent basis, thereby requiring emergency production of medical devices, ranging from test kits to the ventilator parts.
Medical Device Contract Manufacturing Market Segment Analysis:
Medical Device Contract Manufacturing Market by Device Type (IVD Devices, Drug Delivery Devices, Diagnostic Imaging Devices, Patient Monitoring Devices, Cardiovascular Devices, Orthopedic Devices And Others), By Service (Device Development And Manufacturing Services, Quality Management Services, And Final Goods Assembly Services), By Application (Laparoscopy, Pulmonary, Urology & Gynecology, Cardiovascular, Orthopedic, And Others), and by Geography (North America, Europe, Asia-Pacific, and Rest of the World)
In the product type segment of the Medical Device Contract Manufacturing market, the In-Vitro Diagnostics (IVD) Devices is estimated to account for significant revenue share in the year 2023. This can be attributed to a number of different factors including the rising IVD test volume across the globe, development of healthcare infrastructure and the rise in the number of hospitals in the developing regions, increasing use of in vitro diagnostic kits for the diagnosis of COVID-19.
The In vitro diagnostics medical devices offer a variety of benefits and are used in varying applications, ranging from self-tests from pregnancy and blood glucose tests for diabetics to sophisticated diagnoses being performed in clinical laboratories. The use of IVD devices is continuously spurring in medical facilities as the adoption rate for these devices is much higher among the end-users. The demand for point of care devices and their ability to monitor, diagnose and prevent the diseases is also helping in contributing the segment's growth. Additionally, there use in diagnosing the infection with SARS-CoV-2 virus has also led to an augmentation of the IVD market growth. IVD tests offer several advantages in detection of COVID-19, such as quicker detection of the virus, non-invasive point-of-care devices that help in curing, treatment and detection of the virus.
Furthermore, there are several market players that are engaged in the implementation of the strategic initiatives such as mergers & acquisition, new product launch and others are contributing to the segmental growth. For instance, in August 2022, Tecan acquired Paramit, a global contract development and manufacturing company mainly focused on medical devices and life sciences instruments. The acquisition of Paramit is believed to further expand Tecan's position in solutions for life sciences and in-vitro diagnostics (IVD).
North America is expected to dominate the overall Medical Device Contract Manufacturing Market:
Among all the regions, North America is projected to amass the largest share in revenue generation in the Global Medical Device Contract Manufacturing market. Some of the factors responsible for the growth of the North America Medical Device Contract Manufacturing market is the rising incidence of patients suffering from chronic disorders, high levels of unhealthy eating and drinking habits amongst people living in the United States, increasing incidence of cancer cases and the rising technological advancement associated with medical devices.
One of the prominent markets in the North American region is the United States. An increase in patients suffering from cancer is one the key factors leading to the growing need for medical devices that can help in the diagnosis and treatment of cancer, thereby causing an increase in the overall growth of Medical Device Contract Manufacturing market. For instance, as per the American Cancer Society 2020, in the year 2020, there were about 1.8 million new cancer cases that were diagnosed and about 606,520 deaths reported due to cancer in the United States region.
Additionally, an increase in the outsourcing activities for the development of medical devices via the companies engaged in contract manufacturing will also lead to an increase in the demand of the medical device contract manufacturing market, thereby spurring the medical device contract manufacturing market growth. For instance, in October 2020, Relay medical Corporation and Fio Corporation, along with the Fionet Rapid Response Group, had announced that its Fionet pandemic response devices will be produced by the United States-based, FDA approved contract manufacturer, also known as Keytronic, which offers both the turn key services and global reach. The company had also reported producing the COVID-19 related medical devices recently.
Medical Device Contract Manufacturing Market Key Players:
Some of the key market players operating in the Medical Device Contract Manufacturing market includes Flex, Ltd., Integer Holdings Corporation, Gerresheimer AG, Sanmina Corporation, Nipro Corporation, Celestica International Lp., Plexus Corp., Benchmark Electronics Inc., and West Pharmaceutical Services, Inc., Jabil Inc., Tecomet Inc., Nortech Systems Inc., TE Connectivity, Forefront Medical Technologies, Nordson Corporation and others.
Recent Developmental Activities in Medical Device Contract Manufacturing Market:
On July 27, 2022, ILC Dover had acquired the medical device contract design and manufacturing organization (CDMO) Flexan.
In May 2019, Catalent, Inc. had completed the acquisition of Paragon Bioservices, Inc., a contract research and manufacturing organization, for $1.2 billion.
On December 30, 2020, Moderna Inc. and Recipharm AB, a CDMO had drafted an agreement to support the formulation and fill-finish a part of the Moderna COVID-19 Vaccine supply outside the U.S.
Key Takeaways from the Medical Device Contract Manufacturing Market Report Study
Target Audience who can be benefited from this Medical Device Contract Manufacturing Market Report Study
Frequently Asked Questions for Medical Device Contract Manufacturing Market:
Medical Devices Contract Manufacturing Organizations (CMOs) are companies which provide drug development and drug manufacturing services in the pharmaceutical industry on a contract basis. Contract manufacturing organizations take a pre-formulated drug and then help in manufacturing it.
The global medical device contract manufacturing market is projected to grow at a 10.82% CAGR during the forecast period (2024-2030).
The Medical Device Contract Manufacturing market is witnessing an explosion in product demand due to numerous reasons such as the rising prevalence of chronic disorders. Another contributing factor is the rising advancements in the healthcare, medical and the biomedical technology along with the rising expansion and development of skilled and technologically superior healthcare infrastructure and medical facilities.
Some of the key market players operating in the Medical Device Contract Manufacturing market includes Flex, Ltd., Integer Holdings Corporation, Gerresheimer AG, Sanmina Corporation, Nipro Corporation, Celestica International Lp., Plexus Corp., Benchmark Electronics Inc., and West Pharmaceutical Services, Inc., Jabil Inc., Tecomet Inc., Nortech Systems Inc., TE Connectivity, Forefront Medical Technologies, Nordson Corporation and others.
Among all the regions, North America is projected to amass the largest share in revenue generation in the Medical Device Contract Manufacturing market. Some of the factors responsible for the growth of the North America Medical Device Contract Manufacturing market is the rising demand for complex and affordable medical devices, rising expansion and development of skilled and technologically superior healthcare infrastructure and medical facilities, rising prevalence of chronic disorders and the rising growth in the geriatric population.